Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy

CHEST May 2024, Volume 165, Issue 5 CHEST® journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the journal CHEST May 2024 issue, including studies into the costs associated with COPD, now and in the future; the impact of postinterview communication practices on fellowship applicants and program directors; and the epidemiology of intensive care patients classified as a third sex in Australia and New Zealand.

Mira M. John, MD, and Başak Çoruh, MD, join CHEST Podcast Moderator Gretchen Winter, MD, to discuss postinterview communication practices among fellowship applicants and program directors.

Janani S. Reisenauer, MD; Patrick W. Eiken, MD; and Dawn Owen, MD PhD, join journal CHEST Podcast Moderator Dominique Pepper, MD, to discuss new research comparing outcomes for metastasis-directed therapies including sublobar resection, stereotactic body radiation therapy, and percutaneous ablation.

CHEST® journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key research published in the April 2024 issue, including studies into predictors of treatment response to bronchial thermoplasty, individual risk factors that may influence the effect of acute outdoor air pollution on outcomes in individuals with COPD, and urban-rural differences in mortality rates for individuals with idiopathic pulmonary fibrosis. https://journal.chestnet.org/issue/S0012-3692(23)X0006-3

CHEST April 2024, Volume 165, Issue 4 Elizabeth S. Munroe, MD, joins CHEST Podcast Moderator Dominique Pepper, MD, to discuss the use of vasopressors in routine practice and potential associations between vasopressor initiation route and in-hospital mortality. DOI: https://doi.org/10.1016/j.chest.2023.10.027   Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

CHEST April 2024, Volume 165, Issue 4 Sonia Graziano, PsyD, joins CHEST Podcast Moderator Gretchen Winter, MD, to discuss how elexacaftor/tezacaftor/ivacaftor affects mental health, cognitive processing, neuropsychological side effects, GI symptoms, and health-related quality of life in people with cystic fibrosis. DOI: https://doi.org/10.1016/j.chest.2023.10.043   Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

CHEST journal's Editor in Chief, Peter Mazzone, MD, MPH, FCCP, highlights key articles published in the CHEST March 2024 issue.

Melissa L. New, MD, joins CHEST Podcast Moderator Dominique Pepper, MD, to discuss whether the simulation for hemoptysis management improves competence. DOI: https://doi.org/10.1016/j.chest.2023.10.013   Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.  

CHEST March  2023, Volume 165, Issue 3 Allison C. Welch, MPH, and Jed A. Gorden, MD join CHEST Podcast Moderator, Alice Gallo de Moraes, MD, FCCP, to discuss how American Indian and Alaska Native adults perceive and use lung cancer screening.   DOI: https://doi.org/10.1016/j.chest.2023.10.025   Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

CHEST In this episode, Podcast Moderator, Gretchen Winter, MD, discusses strategic planning for the chest clinician with Dr. Stoller in part six of the six-part podcast series. Article Collection: https://journal.chestnet.org/leadership   Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers’ opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.